title: [Analyses of therapeutic and prognostic factors for rN3 neck recurrence of nasopharyngeal carcinoma after primary radiotherapy].
abstract: OBJECTIVE
  To investigate the treatment and prognosis for rN3 neck recurrence of nasopharyngeal carcinoma (NPC) after primary radiotherapy.
  
  
  METHODS
  A total of 37 cases with rN3 neck recurrence after radiotherapy in NPC between October 2003 and August 2013 were retrospectively analyzed. Of them 19 cases presented with lymph node (LN) metastasis in supraclavicular fossa, 18 cases had metastasis LN > 6 cm, 10 cases received chemoradiotherapy, and 27 cases underwent neck dissection including modified radical neck dissection (MRND) for 9 cases, radical neck dissection (RND) for 18 cases. Six of 18 cases with RND underwent reconstructive surgery with pectoralis major flap, 12 cases received postoperative radiotherapy and 20 cases had postoperative adjuvant chemotherapy.
  
  
  RESULTS
  Eight patients had documented recurrence or residue, 17 patients developed distant metastases, one patient showed recurrence and distant metastasis. The 5-year overall survival rate and disease-free survival rate were 27.5% and 21.6% respectively, and the median survival time was 41 months. The survival rate in surgery group was significantly higher than that in chemoradiotherapy group, and the prognosis of patients with LN > 6 cm was better than that of patients with metastasis LN to supraclavicular fossa.
  
  
  CONCLUSIONS
  Patients with rN3 NPC are prone to metastasis, and patients with supraclavicular fossa lymph node metastasis had poor prognosis. Surgery combined with chemoradiotherapy is an effective treatment for the patients without distant metastasis.
authors.affiliation: Department of Otolaryngology Head and Neck Tumor, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China; Email: syfklxf@126.com.
authors.forename: Yongfeng
authors.initials: Y
authors.lastname: Si
authors.affiliation: Department of Otolaryngology Head and Neck Tumor, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China.
authors.forename: Jingjin
authors.initials: J
authors.lastname: Weng
authors.affiliation: Department of Otolaryngology Head and Neck Tumor, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China.
authors.forename: Zhuoxia
authors.initials: Z
authors.lastname: Deng
authors.affiliation: Department of Otolaryngology Head and Neck Tumor, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China.
authors.forename: Guiping
authors.initials: G
authors.lastname: Lan
authors.affiliation: Department of Otolaryngology Head and Neck Tumor, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China.
authors.forename: Yangda
authors.initials: Y
authors.lastname: Qin
authors.affiliation: Department of Otolaryngology Head and Neck Tumor, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China.
authors.forename: Zheng
authors.initials: Z
authors.lastname: Zhang
authors.affiliation: Department of Otolaryngology Head and Neck Tumor, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China.
authors.forename: Yongli
authors.initials: Y
authors.lastname: Wang
authors.affiliation: Department of Otolaryngology Head and Neck Tumor, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China.
authors.forename: Jinlong
authors.initials: J
authors.lastname: Lu
authors.affiliation: Department of Otolaryngology Head and Neck Tumor, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China.
authors.forename: He
authors.initials: H
authors.lastname: Jiang
authors.affiliation: Department of Otolaryngology Head and Neck Tumor, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China.
authors.forename: Jinjie
authors.initials: J
authors.lastname: Sun
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols; D002277:Carcinoma; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D006801:Humans; D008198:Lymph Nodes; D008207:Lymphatic Metastasis; D000077274:Nasopharyngeal Carcinoma; D009303:Nasopharyngeal Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D009333:Neck; D037981:Neck Dissection; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome